| SARM1 is a multi-functional NAD (P) ase with prominent base exchange activity, all regulated bymultiple physiologically relevant NAD metabolites C Angeletti, A Amici, J Gilley, A Loreto, AG Trapanotto, C Antoniou, ... Iscience 25 (2), 2022 | 85 | 2022 |
| Dopamine neuron-derived IGF-1 controls dopamine neuron firing, skill learning, and exploration A Pristerà, C Blomeley, E Lopes, S Threlfell, E Merlini, D Burdakov, ... Proceedings of the National Academy of Sciences 116 (9), 3817-3826, 2019 | 78 | 2019 |
| Selective inhibitors of SARM1 targeting an allosteric cysteine in the autoregulatory ARM domain HC Feldman, E Merlini, C Guijas, KE DeMeester, E Njomen, EM Kozina, ... Proceedings of the National Academy of Sciences 119 (35), e2208457119, 2022 | 68 | 2022 |
| Neurotoxin-mediated potent activation of the axon degeneration regulator SARM1 A Loreto, C Angeletti, W Gu, A Osborne, B Nieuwenhuis, J Gilley, ... Elife 10, e72823, 2021 | 64 | 2021 |
| Mitochondrial dysfunction as a trigger of programmed axon death E Merlini, MP Coleman, A Loreto Trends in Neurosciences 45 (1), 53-63, 2022 | 62 | 2022 |
| NMN: The NAD precursor at the intersection between axon degeneration and anti-ageing therapies A Loreto, C Antoniou, E Merlini, J Gilley, MP Coleman Neuroscience Research 197, 18-24, 2023 | 35 | 2023 |
| Potent activation of SARM1 by NMN analogue VMN underlies vacor neurotoxicity A Loreto, C Angeletti, W Gu, A Osborne, B Nieuwenhuis, J Gilley, ... BioRxiv, 2020.09. 18.304261, 2020 | 16 | 2020 |
| SARM1 is a multi-functional NAD (P) ase with prominent base exchange activity, all regulated bymultiple physiologically relevant NAD metabolites. iScience 25: 103812 C Angeletti, A Amici, J Gilley, A Loreto, AG Trapanotto, C Antoniou, ... Cited Here, 2022 | 12 | 2022 |
| Programmed axon death: a promising target for treating retinal and optic nerve disorders A Loreto, E Merlini, MP Coleman Eye 38 (10), 1802-1809, 2024 | 10 | 2024 |
| SARM1 activation induces reversible mitochondrial dysfunction and can be prevented in human neurons by antisense oligonucleotides A Loreto, KML Cramb, LA McDermott, C Antoniou, I Cirilli, MC Caiazza, ... Neurobiology of disease 213, 106986, 2025 | 8 | 2025 |
| Chronically low NMNAT2 expression causes sub-lethal SARM1 activation and altered response to nicotinamide riboside in axons C Antoniou, A Loreto, J Gilley, E Merlini, G Orsomando, MP Coleman Molecular Neurobiology 62 (3), 3903-3917, 2025 | 7 | 2025 |
| Social network dynamics throughout clinical training—Distance matters L Badawy, P Oza, R Shankarghatta, E Merlini Medical Education 55 (4), 541, 2020 | 3 | 2020 |
| Programmed axon death as a driver of environmental neurotoxicity triggered by pyridine derivatives E Merlini | | 2024 |
Andrea LoretoUniversity of SydneyVerified email at sydney.edu.au
